Medium-sized pharmaceutical firms turn eyes to new products launching

Published: 2003-06-18 07:00:00

Updated: 2003-06-18 07:00:00

In a desperate attempt to spark some life into the depressed domestic pharmaceutical market, major medium-sized pharmaceutical firms are launching a variety of their new products to prop up their market shares in parallel with more fierce marketing undertakings on conventional products.

Busine...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK